ALICIA LOPER: Open Payments
NPI 1144795782 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 47 payments from 10 companies in 2025. Trend: 2023 $354 · 2024 $556 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $368 |
| PFIZER INC. | 8 | $163 |
| Astellas Pharma US Inc | 6 | $142 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Novo Nordisk Inc | 2 | $45 |
| Hologic Sales and Service, LLC | 2 | $35 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: VRAYLAR, Veozah, NURTEC ODT, AIRSUPRA, QULIPTA, TRINTELLIX, APTIMA, UBRELVY.
Industry payments across PA — which companies pay providers there.
